Drugs / tenofovir diisopropyl fumarate
last change Jun 2022 re-read 2 minutes ago

tenofovir diisopropyl fumarate

Developed for
psoriasis
Investigated by
Nîmes University Hospital

Trials 1 · a red edge is where a trial was stopped

2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT04274595 Feb 2020 → Nov 2021 psoriasis Nîmes University Hospital Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as tenofovir diisopropyl fumarate “200mg emtricitabine plus 245mg tenofovir diisopropyl fumarate for 7 days” NCT04274595